Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

Market Cap	88.60B +12.7%
Revenue (ttm)	113.78B +6.9%
Net Income	9.29B +90.1%
EPS	613.00 +90.4%
Shares Out	15.17M
PE Ratio	9.53
Forward PE	n/a
Dividend	60.00 (1.02%)
Ex-Dividend Date	Dec 29, 2025

Volume	56,320
Average Volume	68,534
Open	5,900.00
Previous Close	5,880.00
Day's Range	5,830.00 - 5,960.00
52-Week Range	5,020.00 - 8,730.00
Beta	0.22
RSI	57.90
Earnings Date	May 13, 2026

About Sinsin Pharmaceutical

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The co...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 356
• Stock Exchange: KOSDAQ
• Ticker Symbol: 002800

Financial Performance

In 2025, Sinsin Pharmaceutical's revenue was 113.78 billion, an increase of 6.95% compared to the previous year's 106.39 billion. Earnings were 9.29 billion, an increase of 90.08%.